Nasafi cancer ... a rare disease that is difficult to discover
Nasal pharynx cancer is a cancer found in the nasopharynx, located behind your nose and above the back of your throat. Nasal pharynx cancer is a rare disease in the United States. There are more often in other parts of the world, specifically in Southeast Asia. Nasal pharynx cancer is difficult to detect early. Perhaps this is due to the fact that the nasopharynxes are not easy to investigate, and that the symptoms of nasopharynx cancer simulate the symptoms of other most common conditions. Nasal pharynx treatment usually includes the use of radiotherapy, chemotherapy or a mixture of the two. You can work with your doctor to determine the treatment approach based on your own condition. Symptoms of nasopharynx cancer and in the early stages nasal pharynx cancer can result in no symptoms. The possible noticeable symptoms of nasopharynx cancer include the following: a tumor in the neck caused by swollen lymph nlig. Blood in saliva. Bloody secretions of the nose. Steel nose or tinnitus with the ear. Hearing loss. Repeated ear infection. Sore throat. Headache cases. The causes of cancer begin when one or more genetic mutations cause normal cell growth out of control, enter the surrounding structures and eventually move to other body parts. In the nasal pharynx cancer, the process begins in the exploration cell containing the surface of the nasopharynx. The cause of the genetic mutation leading to the basal cell cancer of the nasal pharynx is ‘unknown’, but the factors that increase the risk of cancer, such as the Epstein Bar virus, have been identified. However, it is not yet clear why people suffering from all risk factors are not affected by cancer, while others have not suffered from risk factors. Treatment works together the patient and the doctor to develop a treatment plan based on various factors, such as the stage of cancer, the goals of treatment, your overall health and the side effects that are ready to wear it. Nasafi cancer treatment usually starts with radiotherapy, or with a mixture of radiotherapy and chemotherapy. Radiotherapy uses high -energy radiotherapy, firmness, such as X -Rays or protons to eliminate cancer cells. Nasal pharynx cancer is usually received in a procedure called external radiation beams. During this procedure, the patient is placed on a table and the maneuver with a large device is performed around it, and radiation is directed to the specified place where it can target cancer. For small pharynx crops, radiotherapy can be the only necessary treatment. Radiation and chemotherapy can be combined in other cases. Radiotherapy poses the risk of side effects, including temporary redness, hearing loss and dry mouth. It is sometimes used as a type of internal radiotherapy, called (topical radiotherapy), in regular nasopharynx cancer. With this treatment, the seeds or radioactive wires are placed in the crop or very close to it. It often causes radiotherapy in the head and neck, especially when associated with chemotherapy, severe sores in the throat and mouth. These ulcers usually cause trouble swallowing or drinking. And if that happens, the doctor may recommend going into a tube in the throat or stomach. Food and water are received by the tube until the mouth and throat are healed. Chemotherapy is known as chemotherapy with drug therapy using chemicals to eliminate cancer cells. Chemotherapy medication can be taken in the form of pills or by intravenous or both. Chemotherapy can be used to treat nasopharynx cancer in three methods: chemotherapy at the same time as radiotherapy. If the treatment is combined, chemotherapy increases the effectiveness of radiotherapy. This mixed therapy is associated with the associated therapy or ‘radiological kimo’ therapy. However, the side effects of chemotherapy are added to the side effects of radiotherapy, making the associated treatment tolerance more difficult. Chemotherapy to radiotherapy. The doctor may recommend chemotherapy after radiotherapy or after associated treatment. Chemotherapy is used to attack any remaining cancer cells in the body, including cells separated from the original crop and distributed elsewhere. There is some controversy over whether the additional chemotherapy improves people with nasopharynx cancer. Many people who undergo chemotherapy after associated treatment cannot withstand side effects, and the treatment should not be continued. Chemotherapy before radiotherapy. Auxiliary provisional therapy is a chemotherapy performed before radiotherapy alone or before the associated treatment. More research is needed to determine if an introductory preliminary therapy can improve survival rates in people with nasophary cancer.